Trial Profile
Phase I trial of EP 217609 in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs EP 217609 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Endotis Pharma
- 03 Jun 2016 Results published in the European Journal of Clinical Pharmacology
- 07 Mar 2011 New trial record
- 08 Jul 2010 Results presented at the 21st International Congress on Thrombosis, according to a Endotis media release.